GB201609354D0 - Transient transfection method for retroviral production - Google Patents

Transient transfection method for retroviral production

Info

Publication number
GB201609354D0
GB201609354D0 GBGB1609354.4A GB201609354A GB201609354D0 GB 201609354 D0 GB201609354 D0 GB 201609354D0 GB 201609354 A GB201609354 A GB 201609354A GB 201609354 D0 GB201609354 D0 GB 201609354D0
Authority
GB
United Kingdom
Prior art keywords
transient transfection
transfection method
retroviral production
retroviral
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609354.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Priority to GBGB1609354.4A priority Critical patent/GB201609354D0/en
Publication of GB201609354D0 publication Critical patent/GB201609354D0/en
Priority to IT102016000117287A priority patent/IT201600117287A1/en
Priority to GB1619642.0A priority patent/GB2544891B/en
Priority to JP2018526787A priority patent/JP7110096B2/en
Priority to FR1661254A priority patent/FR3044017B1/en
Priority to BR112018010639A priority patent/BR112018010639A2/en
Priority to DE102016122317.4A priority patent/DE102016122317A1/en
Priority to AU2016359838A priority patent/AU2016359838B2/en
Priority to US15/356,813 priority patent/US10450574B2/en
Priority to CA3006285A priority patent/CA3006285A1/en
Priority to KR1020187014239A priority patent/KR102067352B1/en
Priority to RU2018118964A priority patent/RU2749717C2/en
Priority to PCT/EP2016/078334 priority patent/WO2017089307A1/en
Priority to CN201680068697.3A priority patent/CN108291211A/en
Priority to EP16798223.0A priority patent/EP3380605A1/en
Priority to IL259223A priority patent/IL259223B/en
Priority to SA518391585A priority patent/SA518391585B1/en
Priority to US16/658,293 priority patent/US20200063144A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB1609354.4A 2015-11-24 2016-05-26 Transient transfection method for retroviral production Ceased GB201609354D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB1609354.4A GB201609354D0 (en) 2016-05-26 2016-05-26 Transient transfection method for retroviral production
EP16798223.0A EP3380605A1 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
US15/356,813 US10450574B2 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
KR1020187014239A KR102067352B1 (en) 2015-11-24 2016-11-21 Transient Transfection Methods for Retrovirus Production
JP2018526787A JP7110096B2 (en) 2015-11-24 2016-11-21 Transient transfection method for retrovirus production
FR1661254A FR3044017B1 (en) 2015-11-24 2016-11-21 TRANSIENT TRANSFECTION METHOD FOR RETROVIRAL PRODUCTION
BR112018010639A BR112018010639A2 (en) 2015-11-24 2016-11-21 transient transfection method for retroviral production.
DE102016122317.4A DE102016122317A1 (en) 2015-11-24 2016-11-21 TRANSIENT TRANSFECTION PROCEDURE FOR RETROVIRAL PRODUCTION
AU2016359838A AU2016359838B2 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
IT102016000117287A IT201600117287A1 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production.
CA3006285A CA3006285A1 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
GB1619642.0A GB2544891B (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
RU2018118964A RU2749717C2 (en) 2015-11-24 2016-11-21 Method for temporary transfection for producing retrovirus
PCT/EP2016/078334 WO2017089307A1 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production
CN201680068697.3A CN108291211A (en) 2015-11-24 2016-11-21 Transient transfection method for generating retrovirus
IL259223A IL259223B (en) 2015-11-24 2018-05-08 Transient transfection method for retroviral production
SA518391585A SA518391585B1 (en) 2015-11-24 2018-05-15 Transient transfection method for retroviral production
US16/658,293 US20200063144A1 (en) 2015-11-24 2019-10-21 Transient transfection method for retroviral production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609354.4A GB201609354D0 (en) 2016-05-26 2016-05-26 Transient transfection method for retroviral production

Publications (1)

Publication Number Publication Date
GB201609354D0 true GB201609354D0 (en) 2016-07-13

Family

ID=56410642

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1609354.4A Ceased GB201609354D0 (en) 2015-11-24 2016-05-26 Transient transfection method for retroviral production
GB1619642.0A Active GB2544891B (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1619642.0A Active GB2544891B (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production

Country Status (1)

Country Link
GB (2) GB201609354D0 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277621B1 (en) * 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences
US7214515B2 (en) * 2001-01-05 2007-05-08 The General Hospital Corporation Viral delivery system for infectious transfer of large genomic DNA inserts
WO2003087330A2 (en) * 2002-04-10 2003-10-23 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vac-bac shuttle vector system
US20080226677A1 (en) * 2004-05-06 2008-09-18 Yasuko Mori Recombinant virus vector for gene transfer into lymphoid cells
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
US20110027313A1 (en) * 2008-04-04 2011-02-03 University Of Miami Viral recombineering and uses thereof

Also Published As

Publication number Publication date
GB2544891B (en) 2017-11-15
GB2544891A (en) 2017-05-31
GB201619642D0 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
IL259223B (en) Transient transfection method for retroviral production
IL282603B (en) Stable cell lines for retroviral production
EP3398960A4 (en) Method for preparing sermaglutide
IL247937A0 (en) Process for making membranes
EP3287439A4 (en) Method for preparing taurine
HUE047167T2 (en) Method for making isocyanates
EP3321272A4 (en) Method for preparing l-bpa
SG11201702450QA (en) Hydroprocessing for distillate production
HUE054696T2 (en) Production method for lgps-based solid electrolyte
PL3604216T3 (en) Production method for solid electrolyte having li3ps4
GB201715167D0 (en) Methods for hydrogen production
ZA201808135B (en) Process for making micro-aerated choco-material
EP3388055A4 (en) Method for preparing liposome
IL249765A0 (en) Precise positioning method
HUE060897T2 (en) Method for making isocyanates
PT3362405T (en) Process for the production of methanol
HUE047039T2 (en) Method for producing isocyanates
GB201508425D0 (en) Artificial chromosome for retroviral production
SG11202004021RA (en) Production method for dihydroxyindoles
IL257814B (en) Method for the production of praziquantel
PL3508512T3 (en) Method for preparing polycarbonate
HUE055196T2 (en) Method for making isocyanates
EP3315585A4 (en) Ferro-coke production method
ZA201903463B (en) Method for preparing hexadecahydropyrene
GB2544891B (en) Transient transfection method for retroviral production

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)